The North America Drug Delivery Market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.
North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

Market Overview
North America dominates the global drug delivery market, with the United States accounting for the largest share, followed by Canada. The region’s market growth is driven by rising demand for rare disease treatments from biopharmaceutical and biotechnology firms, the strong presence of major industry players, and significant research and development activities carried out by academic and research institutions. Additionally, ongoing advancements in pharmaceutical and biotechnology research are anticipated to further fuel the expansion of the drug delivery market in North America throughout the forecast period.
Get Sample PDF of this Report @
https://www.businessmarketinsights.com/sample/BMIRE00028761
According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 adults in the U.S. were living with at least one chronic disease, while around 4 in 10 had two or more chronic conditions as of 2019. Patients with chronic illnesses often experience worsening health over time, placing a significant burden on their families and society as a whole. The American Cancer Society (ACS) projects that the U.S. will see approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths in 2023. Diabetes, another life-threatening chronic disease with no definitive cure, can lead to severe complications such as heart attacks, strokes, kidney failure, limb amputations, vision loss, and nerve damage, all of which increase the risk of premature death. The prevalence of diabetes has been rising sharply worldwide, underscoring the growing need for effective management and treatment solutions.
North America Drug Delivery Market Segmentation
- The North America drug delivery market is segmented on the basis of route of administration, distribution channel, end user, and country.
- Based on route of administration, the North America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest share of the North America Drug Delivery market in 2023.
- Based on distribution channel, the North America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2023.
- Based on end user, the North America drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the market in 2023.
- Based on country, the North America drug delivery market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America drug delivery market in 2023.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications